The prediction potential of neutrophil-to-lymphocyte ratio for the therapeutic outcomes of programmed death receptor-1/programmed death ligand 1 inhibitors in non-small cell lung cancer patients: A meta-analysis

BACKGROUND: Programmed death receptor-1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors have been demonstrated to improve the prognosis of patients with advanced non-small cell lung cancer (NSCLC) compared with chemotherapy. However, there were still some non-responders. Thus, how to effectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ying, Shen, Aizong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447402/
https://www.ncbi.nlm.nih.gov/pubmed/32846790
http://dx.doi.org/10.1097/MD.0000000000021718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447402/
https://www.ncbi.nlm.nih.gov/pubmed/32846790
http://dx.doi.org/10.1097/MD.0000000000021718

Ejemplares similares